Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

High-tech rehabilitation program for adults with acute neuromuscular disease

Official title: Clinical Protocol for a Pragmatic Trial on a High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases (Fit4MedRob-Acute MND Project)

Run by Istituti Clinici Scientifici Maugeri SpA · NCT06822231 · Data updated 2026-11-12

This trial will test whether a high-tech rehab program using robotics, virtual reality, and balance platforms helps adults with acute neuromuscular conditions improve balance, strength, fatigue, and quality of life more than usual therapy.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment124 (estimated)
SponsorIstituti Clinici Scientifici Maugeri SpA
Academic / other
Locations8 sites (Bari and 7 other locations)
StatusRecruiting
StartedMay 28, 2025
Main results expectedMay 2027
Study endsJune 2027
Registry record updatedNovember 4, 2026
Trial IDNCT06822231 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–80 with a confirmed acute/subacute neuromuscular diagnosis (GBS, CIM, CIP) within 15–30 days of onset, with at least MRC ≥2 in two lower-limb muscle groups and able to give informed consent are ideal candidates.

Probably not a fit

Patients with unstable medical conditions (for example NYHA class IV heart failure), uncompensated respiratory failure, very low lower-limb strength (MRC <2), pregnant or breastfeeding women, or those enrolled in conflicting trials are unlikely to be eligible or to benefit from the protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, parallel-assignment study compares a high-tech rehabilitation circuit (robotic systems, virtual reality, stabilometric platforms) to conventional rehabilitation in adults with acute/subacute neuromuscular diseases such as Guillain-Barré syndrome, critical illness myopathy, and critical illness polyneuromyopathy. Participants aged 18–80 within 15–30 days of symptom onset and with minimum preserved lower-limb strength will be randomized to receive either the advanced-technology protocol or standard care. The protocol emphasizes intensive, rapid rehabilitation with repeated, standardized sessions delivered by multidisciplinary teams and uses the Berg Balance Scale and other motor, fatigue, sarcopenia, cognitive engagement, and quality-of-life measures as outcomes. The primary outcome is a predefined improvement in balance (at least 10 points on the Berg Balance Scale) from baseline to end of treatment.

Why it matters

Potential benefit: If successful, this program could speed and enhance recovery of balance, strength, and daily function compared with standard rehabilitation for patients with acute neuromuscular diseases.

How similar studies have gone: Related robotic and virtual-reality rehabilitation approaches have shown benefits in stroke and chronic neuromuscular rehabilitation, but rigorous randomized evidence specifically in acute neuromuscular diseases is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults with ages ranging from 18 to 80 years.
* Patients with a confirmed diagnosis of acute/subacute neuromuscular diseases (e.g. GBS, CIM, CIP)
* Time of onset ranging from 15 to 30 days
* Patients with lower limb strength (Medical Research Council or MRC) \>=2 in at least two of the flexor and extensor muscles of the following joints: hip, knee and ankle
* Possibility of obtaining informed consent

Exclusion Criteria:

* Patients with unstable medical conditions (e.g. severe cardiovascular diseases, such as "New York Heart Association" - NYHA=4, respiratory distress not compensated by ventilation) that could interfere, in the clinician's judgment, with their ability to safely participate in the study or to perform the assessments related to the protocol.
* Patients currently participating in other clinical trials that could interfere with this study.
* Pregnant or breastfeeding women.

Where it's running

  • Istituti Clinici Scientifici Maugeri IRCCS, Milan Institute
    Milan, Italy
    Recruiting
  • Istituti Clinici Scientifici Maugeri
    Bari, Italy
    Not yet recruiting
  • IRCCS Azienda Ospedaliera Universitaria San Martino - Genova
    Genova, Italy
    Not yet recruiting
  • Azienda Ospedaliero-Universitaria di Modena
    Modena, Italy
    Not yet recruiting
  • Istituti Clinici Scientifici Maugeri
    Montescano, Italy
    Not yet recruiting
  • Istituti Clinici Scientifici Maugeri
    Pavia, Italy
    Not yet recruiting
Show 2 more locations
  • Fondazione Don Carlo Gnocchi Onlus
    Roma, Italy
    Not yet recruiting
  • Istituti Clinici Scientifici Maugeri
    Telese Terme, Italy
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.